Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019046850) TETRAHYDROCANNABINOL MODULATORS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/046850 International Application No.: PCT/US2018/049360
Publication Date: 07.03.2019 International Filing Date: 04.09.2018
IPC:
A61K 31/352 (2006.01) ,A61K 45/06 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
335
having oxygen as the only ring hetero atom, e.g. fungichromin
35
having six-membered rings with one oxygen as the only ring hetero atom
352
condensed with carbocyclic rings, e.g. cannabinols, methantheline
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45
Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
06
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Applicants:
SCIENTIFIC HOLDINGS, LLC [US/US]; 181 W. Huntington Drive, #106 Monrovia, CA 91016, US
Inventors:
RABER, Jeffrey, Charles; US
DOUGLASS, Bradley, J.; US
Agent:
GLUCK, Peter, Jon; US
Priority Data:
62/553,81702.09.2017US
Title (EN) TETRAHYDROCANNABINOL MODULATORS
(FR) MODULATEURS DE TÉTRAHYDROCANNABINOL
Abstract:
(EN) The disclosure provides cannabinoid compositions that include delta-8-tetrahydrocannabinol (delta-8-THC), cannabidiol (CBD), delta-9-THG, natural products that reduce catabolism of delta-8-THC, delta-8-THC, 11-hydroxy-delta-8-THC, or of 11-hydroxy-delta-9-THC, as well as pharmaceutically synergic or additive combinations of delta-8-THC and delta-9-THC.
(FR) L'invention concerne des compositions de cannabinoïdes qui comprennent delta-8-tétrahydrocannabinol (delta-8-THC), cannabidiol (CBD), delta-9-THG, des produits naturels qui réduisent le catabolisme de delta-8-THC, delta-8-THC, 11-hydroxy-delta-8-THC, ou de 11-hydroxy-delta-9-THC, ainsi que des combinaisons synergiques ou additives pharmaceutiquement acceptables de delta-8-THC et de delta-9-THC.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)